Filtered By:
Condition: Thrombosis
Procedure: Hemodialysis
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 192 results found since Jan 2013.
Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network
CONCLUSION: The mortality of individuals with SLE due to COVID-19 is comparable to the general population but with higher risks of hospitalisation, ICU admission, mechanical ventilation, stroke, VTE and sepsis. The presence of nephritis increases the risk of AKI, thus probably increasing hospitalisation and sepsis.PMID:34649723 | PMC:PMC8501265 | DOI:10.1016/j.jaut.2021.102730
Source: Journal of Autoimmunity - October 15, 2021 Category: Allergy & Immunology Authors: Rahul Raiker Haig Pakhchanian Charles DeYoung Latika Gupta Sinan Karde ş Sakir Ahmed Chengappa Kavadichanda Source Type: research
Relation of apixaban bleeding rates to dose in patients with chronic kidney disease
The objective of this study was to evaluate the safety and efficacy of apixaban 5 mg twice daily vs 2.5 mg twice daily for nonvalvular atrial fibrillation or venous thromboembolism in patients with chronic kidney disease stage 4 and 5, including those on hemodialysis. Data were collected retrospectively on patients with advanced chronic kidney disease and nonvalvular atrial fibrillation and/or venous thromboembolism who received apixaban while hospitalized at our institution between January 2013 and August 2018. The 5 mg twice daily group included 22 patients, and the 2.5 mg twice daily group included 73 patients. There wa...
Source: Baylor University Medical Center Proceedings - August 30, 2021 Category: Universities & Medical Training Authors: Sarah Yun Regan Sevinsky Tasleem Spracklin Alexandra Tatara Andrew Zoltan Fenves Source Type: research
